Pistoia Alliance April Virtual Conference: Building the Business Value Case of a Digital R&D Transformation

This on-demand recording is part of the Pistoia Alliance Conference: Collaborative R&D in Action, April 20-23, 2021. For more information about related events, please visit our online calendar.

Summary

Digitalization of early-stage biopharmaceutical R&D has the potential to increase productivity, improve collaboration, enhance data integrity, and bolster scientific and operational decision-making. However, while some of these benefits have been realized, the majority of biopharma companies have been unable to measure meaningful business value from their digital R&D solutions.

This presentation will outline an approach to assessing your current level of digital maturity and measuring value from a digital R&D transformation. Real-world examples will be shared from Benchling’s past business value engagements across the life science R&D industry.